ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver transplantation"

  • 2019 American Transplant Congress

    Case Series Of Total Laparoscopic-hand Assisted Living Donor Right Hepatectomy: First 19 Cases At A Single Center In Usa

    P. N. Martins1, B. Movahedi2, D. Litwin2, A. Bozorgzadeh2

    1Surgery, Division of Transplantation, University of Massachusett, Worcester, MA, 2Surgery, Division of Transplantation, University of Massachusetts, Worcester, MA

    *Purpose: One of the major limitations of living-donor liver donation is the associated morbidity of the procedure. Although left and left-lateral hepatectomy has been performed…
  • 2019 American Transplant Congress

    Taking a Step toward Standardization: Results of an American Society of Transplant Surgeons/Association of Organ Procurement Organizations Survey of Donation after Circulatory Death Liver Recovery Practices

    M. Hobeika1, R. Glazner2, D. Foley1, S. Hanish1, C. Quintini1, E. Eidbo2, D. Axelrod1

    1American Society of Transplant Surgeons DCD Task Force, Arlington, VA, 2Association of Organ Procurement Organizations, Vienna, VA

    *Purpose: Donation after circulatory death (DCD) liver transplants (LT) represented only 6.3% of total U.S. LT in 2017, despite DCD comprising 18.3% of the deceased…
  • 2019 American Transplant Congress

    Large Series Of Liver Transplantation In Patients With Portal Vein Thrombosis

    Y. Cheah, C. J. Simon, R. L. Jenkins, M. E. Akoad

    Lahey Hospital & Medical Center, Burlington, MA

    *Purpose: Portal vein thrombosis (PVT) is common in the cirrhotic population and no longer considered an absolute contraindication to liver transplantation in most centers.*Methods: Retrospective…
  • 2019 American Transplant Congress

    Policy Changes in Liver Graft Allocation for Hepatocellular Carcinoma in the USA: Improved Survival for African American Recipients

    M. Molinari1, D. Jorgensen1, A. Tevar1, C. Hughes1, A. Humar1, N. Jonassaint2

    1Surgery, University of Pittsburgh Medical Centre, Pittsburgh, PA, 2Medicine, University of Pittsburgh Medical Centre, Pittsburgh, PA

    *Purpose: To evaluate the effect of policy changes in liver graft allocation for hepatocellular carcinoma (HCC) on the overall survival of patients of different ethnicities…
  • 2019 American Transplant Congress

    Opioid Use Policies and Practices in Liver Transplant and Lung Transplant Candidates: A Comparison of National Surveys

    H. Bruschwein1, V. Andersen1, H. Patel2, S. S. Rogal3, J. N. Fleming4

    1University of Virginia, Charlottesville, VA, 2University of North Carolina, Chapel Hill, NC, 3University of Pittsburgh, Pittsburgh, PA, 4Medical University of South Carolina, Charleston, SC

    *Purpose: Pre-transplant opioid use has been associated with increased risk of morbidity and mortality. Alternatively, opioid substitution therapy (OST) has been proven to be a…
  • 2019 American Transplant Congress

    Pilot Testing Of A Novel Transition Program

    J. Uze, N. Yazigi

    Transplantation, MedStar Georgetown University Hospital, Washigton, DC

    *Purpose: Pediatric patients coming of age face many compliance hurdles, the roots of most lying in poor coping with heir state as a transplant recipient,…
  • 2019 American Transplant Congress

    B7H1 Expression is Crucial for Tolerance Induction in Mouse Liver Transplantation

    M. Morita1, S. Datta1, C. Miller2, T. Hamilton1, K. Hashimoto3

    1Inflammation & Immunity, Lerner Research Institution, Cleveland, OH, 2General surgery, Liver Transplant Center, Cleveland Clinic, Cleveland, OH, 3General Surgery, Liver Transplant Center, Cleveland Clinic, Cleveland, OH

    *Purpose: Following organ transplantation, lifelong immunosuppressive treatment is required and it causes severe side effects. Induction of donor specific tolerance is ideal, which actually spontaneously…
  • 2019 American Transplant Congress

    Early Use of Everolimus Plus Reduced Tacrolimus vs Standard Tacrolimus in De Novo Livertransplant Recipients: 12 Months Efficacy and Safety Data from HEPHAISTOS Study

    B. Nashan1, P. Schemmer1, H. Schlitt1, A. Pascher1, C. Klein1, U. Neumann1, I. Kroeger2, P. Wimmer2, F. Braun1

    1Study Group, Hephaistos, Germany, 2Novartis Pharma GmbH, Nuernberg, Germany

    *Purpose: The HEPHAISTOS study was set up to compare early use of everolimus [EVR] combined with reduced tacrolimus [rTAC] versus standard-dose tacrolimus [TAC-C) in de…
  • 2019 American Transplant Congress

    Transplant Center Practices Are the Primary Drivers of United States Donation after Circulatory Death Liver Transplantation

    L. Beal1, D. T. Nguyen2, T. Menser3, S. Zajac1, E. A. Graviss2, M. J. Hobeika1

    1Department of Surgery, Houston Methodist Hospital, Houston, TX, 2Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, TX, 3Center for Outcomes Research, Houston Methodist Research Institute, Houston, TX

    *Purpose: We hypothesize that a few high-utilization donation after circulatory death (DCD) liver centers are the primary drivers of the dissimilar rates of DCD liver…
  • 2019 American Transplant Congress

    The Outcomes after an Infection in Older Liver Transplant Recipients is Comparable to Younger Adults

    J. Garcia-Diaz1, M. Kerkelis2, T. Shah3, M. Tucker4, M. Gastanaduy5, J. Woo1, M. Ponder1, M. Malinis6, M. Malinis6

    1Infectious Diseases, Ochsner Medical Center, New Orleans, LA, 2University of Queensland/Ochsner Clinical School, New Orleans, LA, 3Internal Medicine, St. Joseph Hospital, Denver, CO, 4Internal Medicine, Yale School of Medicine, New Haven, CT, 5Center for Outcomes and Health Services Research, Ochsner Medical Center, New Orleans, LA, 6Infectious Diseases, Yale School of Medicine, New Haven, CT

    *Purpose: Solid organ transplantation is being increasingly offered to older patients with concurrent chronic medical conditions such as cardiovascular, cerebrovascular, and renal disease. Risk of…
  • « Previous Page
  • 1
  • …
  • 84
  • 85
  • 86
  • 87
  • 88
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences